These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2082484)

  • 1. Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study).
    Sanz G
    Thromb Res Suppl; 1990; 12():23-6. PubMed ID: 2082484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC).
    Sanz G; Pajarón A; Alegría E; Coello I; Cardona M; Fournier JA; Gómez-Recio M; Ruano J; Hidalgo R; Medina A
    Circulation; 1990 Sep; 82(3):765-73. PubMed ID: 2203555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
    Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
    Chesebro JH
    Thromb Res Suppl; 1990; 12():5-10. PubMed ID: 2082487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
    Chesebro JH; Fuster V; Elveback LR; Clements IP; Smith HC; Holmes DR; Bardsley WT; Pluth JR; Wallace RB; Puga FJ
    N Engl J Med; 1984 Jan; 310(4):209-14. PubMed ID: 6361561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial.
    Guiteras P; Altimiras J; Arís A; Augé JM; Bassons T; Bonal J; Caralps JM; Castellarnau C; Crexells C; Masotti M
    Eur Heart J; 1989 Feb; 10(2):159-67. PubMed ID: 2647494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
    Hockings BE; Ireland MA; Gotch-Martin KF; Taylor RR
    Med J Aust; 1993 Sep; 159(6):376-8. PubMed ID: 8377686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and prevention of aortocoronary bypass graft occlusion.
    Chesebro JH; Fuster V
    Int J Clin Pharmacol Res; 1986; 6(4):261-7. PubMed ID: 3531036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
    Cataldo G; Heiman F; Lavezzari M; Marubini E
    Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of early saphenous vein aortocoronary bypass graft occlusion. The GESIC Study Group.
    Paz MA; Lupon J; Bosch X; Pomar JL; Sanz G
    Ann Thorac Surg; 1993 Nov; 56(5):1101-6. PubMed ID: 8239808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion.
    Yli-Mäyry S; Huikuri HV; Korhonen UR; Airaksinen KE; Ikäheimo MJ; Linnaluoto MK; Takkunen JT
    Eur Heart J; 1992 Sep; 13(9):1259-64. PubMed ID: 1396838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
    Fremes SE; Levinton C; Naylor CD; Chen E; Christakis GT; Goldman BS
    Eur J Cardiothorac Surg; 1993; 7(4):169-80. PubMed ID: 8481254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft.
    Thaulow E; Frøysaker T; Dale J; Vatne K
    Scand J Thorac Cardiovasc Surg; 1987; 21(3):215-20. PubMed ID: 3501902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.